Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HMGA2 |
| Upstream (Parents) |
|---|
| (<<) ASNS → HMGA2 |
| (<<) ATIC → HMGA2 |
| (<<) BLNK → HMGA2 |
| (<<) CCNB1 → HMGA2 |
| (<<) CCNE1 → HMGA2 |
| (<<) CDK4 → HMGA2 |
| (<<) E2F3 → HMGA2 |
| (<<) NXT1 → HMGA2 |
| (<<) ORC6L → HMGA2 |
| (<<) PRDX6 → HMGA2 |
| (<<) UBE2C → HMGA2 |
| Downstream (Children) |
|---|
| HMGA2 → ARID3B (>>) |
| HMGA2 → DLX2 (>>) |
| HMGA2 → FGFR3 (>>) |
| HMGA2 → GPRIN2 (>>) |
| HMGA2 → ID1 (>>) |
| HMGA2 → IL23A (>>) |
| HMGA2 → KCNN4 (>>) |
| HMGA2 → MAPK6 (>>) |
| HMGA2 → MRAS (>>) |
| HMGA2 → NUPR1 (>>) |
| HMGA2 → TYRO3 (>>) |
